Bonaventura Clotet

50.8k citations
723 papers · 25.9k · 4 hit papers · h-index 78

Impact in

  • Virology top 0.01%
    • HIV Research and Treatment
    • HIV/AIDS drug development and treatment
    • HIV/AIDS Research and Interventions

Papers in

    • HIV/AIDS drug development and treatment 291
    • HIV/AIDS Research and Interventions 131
    • HIV Research and Treatment 333

Bonaventura Clotet

707 papers receiving 25.0k citations

Bonaventura Clotet's Hit Papers

Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study 2021 · 201 citations
2010+7+15Years since publication100200300400500

Peers

Bonaventura Clotet
Comparison fields: 5 of 170
  • Virology 11.7k
  • Infectious Diseases 14.3k
  • Emergency Medicine 2.7k
  • Hepatology 1.6k
  • Immunology 3.1k
Replace Michael S. Saag with:
Michael S. Saag United States
Joseph J. Eron United States
Margaret A. Fischl United States
John W. Mellors United States
Paul A. Volberding United States
Martin Hirsch United States
Sharon R. Lewin Australia
Huldrych F. Günthard Switzerland
Christine Katlama France
Diane V. Havlir United States
Bonaventura Clotet relative to Michael S. Saag United States Michael S. Saag's profile →
Citations per field
00.5×1.5×
Michael S. Saag · 1×
Citations per year

Countries citing papers authored by Bonaventura Clotet

Since Specialization
Citations

This map shows the geographic impact of Bonaventura Clotet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bonaventura Clotet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bonaventura Clotet more than expected).

Fields of papers citing papers by Bonaventura Clotet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bonaventura Clotet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bonaventura Clotet. The network helps show where Bonaventura Clotet may publish in the future.

Co-authors

The 25 scholars most cited alongside Bonaventura Clotet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bonaventura Clotet Line = papers co-authored together Bonaventura Clotet links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 723 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Maraviroc for Previously Treated Patients with R5 HIV-1 Infection
Hit paper breakdown →
2008591
2
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
Hit paper breakdown →
2003516
3 1998494
4 2003415
5 2008396
6 2007383
7
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study
Hit paper breakdown →
2014368
8 2007328
9 2011299
10 1998281
11 2007277
12 2006256
13
Update of the drug resistance mutations in HIV-1: 2007.
2007248
14
Drug Resistance Mutations in HIV-1.
2003237
15 2002232
16
Update of the drug resistance mutations in HIV-1: Fall 2005.
2006227
17 2001207
18 2006206
19 2002202
20 2008201

About Bonaventura Clotet

Bonaventura Clotet is a scholar working on Infectious Diseases, Virology, Epidemiology, Immunology and Emergency Medicine, having authored 723 papers that have together received 25.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (333 papers), HIV/AIDS drug development and treatment (291 papers), HIV/AIDS Research and Interventions (131 papers), HIV-related health complications and treatments (85 papers), Immune Cell Function and Interaction (65 papers), Hepatitis C virus research (55 papers), Cytomegalovirus and herpesvirus research (28 papers) and Immunotherapy and Immune Responses (24 papers). The work is most often cited by research in Virology (11.7k citations), Infectious Diseases (14.3k citations), Emergency Medicine (2.7k citations), Hepatology (1.6k citations) and Immunology (3.1k citations). Bonaventura Clotet has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Eugènia Negredo, José A. Esté, Julià Blanco, Javier Martínez‐Picado, Miguel Ángel Martı́nez, Roger Paredes, Lı́dia Ruiz, Victoria A. Johnson, Daniel R. Kuritzkes and Douglas D. Richman. Their work appears in journals such as AIDS, Antiviral Therapy, PLoS ONE, Journal of Antimicrobial Chemotherapy and JAIDS Journal of Acquired Immune Deficiency Syndromes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact